Similar Papers

Paper Title
Journal
Date
Author
CAR T-cell therapy for malignant lymphoma
Tomoyasu Jo ... Yasuyuki Arai
[Rinsho ketsueki] The Japanese journal of clinical hematology | VOL. 65
Tomoyasu Jo, et. al.Tomoyasu Jo ... Yasuyuki Arai
01 Jan 2024
Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma
Zhitao Ying ... Jun Zhu
Molecular Therapy - Oncolytics | VOL. 15
Zhitao Ying, et. al.Zhitao Ying ... Jun Zhu
28 Aug 2019
Timing of anti–PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
Alexandre V Hirayama ... Abigail Chutnik
Blood advances | VOL. 8
Alexandre V Hirayama, et. al.Alexandre V Hirayama ... Abigail Chutnik
31 Oct 2023
Data from Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells
Andrea V Lopez ... Sarwish Rafiq
-
Andrea V Lopez, et. al.Andrea V Lopez ... Sarwish Rafiq
04 Apr 2023
View more papers

More From: Blood

Paper Title
Journal
Date
Author
Brentuximab vedotin and nivolumab for cHL.
-
Blood | VOL. 145
--
16 Jan 2025
B-1 B cells lose self-control in SCD.
David R Gibb ... Sean R Stowell
Blood | VOL. 145
David R Gibb, et. al.David R Gibb ... Sean R Stowell
16 Jan 2025
Is it time to screen for multiple myeloma?
Irene M Ghobrial ... Floris Chabrun
Blood | VOL. 145
Irene M Ghobrial, et. al.Irene M Ghobrial ... Floris Chabrun
16 Jan 2025
Daratumumab for maintenance in myeloma.
Cyrille Touzeau ... Aurore Perrot
Blood | VOL. 145
Cyrille Touzeau, et. al.Cyrille Touzeau ... Aurore Perrot
16 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.